RNS Number:1904K
ReGen Therapeutics PLC
17 April 2003

ReGen Therapeutics Plc

FOR IMMEDIATE RELEASE


                                INTERIM FUNDING


London, UK - 17 April 2003: ReGen Therapeutics Plc ("ReGen" or the "Company")
announces that it has today placed 20,000,000 new ordinary shares ("New Shares")
with new and existing shareholders at 0.75p per share raising the Company
#150,000 for general working capital purposes.

Application will be made for the New Shares to be admitted to the Alternative
Investment Market of the London Stock Exchange plc and dealings are expected to
commence at 8.00 am on 25 April 2003.

Executive Chairman Percy Lomax said, "This fundraising, as part of our
continuing fundraising efforts, illustrates the continued support for the
Company in these very difficult market conditions.   It will help, along with
our recently acquired investment trust shares, to provide funding for our
ongoing development programme.  We also now continue to explore further
fundraising and acquisition opportunities."

For further information please contact:

Andrew Marshall
Marshall Robinson Roe
Tel No 020 7489 2033


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

IOESFUFMWSDSESL